COVID-19
STILL offering monoclonal antibody infusion to treat COVID-19!
For those not ill with COVID-19, there is a long-acting monoclonal antibody called (Evusheld).
STILL offering monoclonal antibody infusion to treat COVID-19!
The new monoclonal antibody (Bebtelovimab) is for treatment of COVID-19 in the first 7 days of illness. It is effective against all variants of COVID and indicated for adults and pediatric patients (12 years of age and older weighing at least 88 pounds).
For those not ill with COVID-19, there is a long-acting monoclonal antibody called (Evusheld).
STILL offering monoclonal antibody infusion to treat COVID-19!
For those not ill with COVID-19, there is a long-acting monoclonal antibody called (Evusheld).
For those not ill with COVID-19, there is a long-acting monoclonal antibody called (Evusheld).
For those not ill with COVID-19, there is a long-acting monoclonal antibody called (Evusheld).
Evusheld is administered as two intra-muscular injections at the same visit. This medication works by the same mechanism as the more well-known antibody infusions. Instead of being given when you are sick, this medication is given before illness to prevent severe illness, and designed for those who are immunocompromised/unable to get the vaccine/etc.
You can add this on to your visit for $50.
We aren't able to take any new patients at this time; please check back as we will provide updates when we can. Thank you, Jason